Showing results (201-210 of 225) with videos related to
Sort By:
Pageof 23
BMJ Open|December 29, 2020
Protocol to assess the efficacy of carnosine supplementation in mitigating the adverse cardiovascular responses to particulate matter (PM) exposure: the Nucleophilic Defense Against PM Toxicity (NEAT) trialTimothy E O'Toole, Alok A Amraotkar, Andrew P DeFilippis, et al.Antioxidants (Basel, Switzerland)|September 17, 2020
NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney CortexAdrienne Bushau-Sprinkle, Michelle T Barati, Kenneth B Gagnon, et al.Nature Communications|June 23, 2026
Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integritySweta Ghosh, Zachary M Vanwinkle, Sobha Rani Bodduluri, et al.Annals of Epidemiology|September 22, 2015
Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancerStephanie D Boone, Kathy B Baumgartner, Richard N Baumgartner, et al.BMC Cancer|December 15, 2011
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanomaSucheta Telang, Mary Ann Rasku, Amy L Clem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's diseaseSarah S Donaldson, Michael P Link, Howard J Weinstein, et al.The Science of the Total Environment|December 23, 2019
Association between residential greenness and exposure to volatile organic compoundsRay Yeager, Daniel W Riggs, Natasha DeJarnett, et al.Scientific Reports|June 24, 2024
Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breathZhenzhen Xie, James D Morris, Jianmin Pan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck CancerOlga Zamulko, Sam Nusbaum, Andrew Osterburg, et al.Environmental Toxicology and Pharmacology|May 3, 2023
Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposureKellianne M Piell, Belinda J Petri, Kimberly Z Head, et al.Pageof 23